Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Rheumatoid Arthritis

Free Subscription 22.04.2024 1 Ann Rheum Dis 1 Arthritis Res Ther 2 Clin Exp Rheumatol 7 Clin Rheumatol 1 Eur J Immunol 1 J Rheumatol 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Rheumatol Int 2 Scand J Rheumatol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Rheum Dis

1. LUO X, Ren Y, Chen Y
   Gender imbalance in expert panels of recommendations in rheumatology.
   Ann Rheum Dis. 2024;83:682-684.
   PubMed        
   
   

   
   Arthritis Res Ther

2. YAMADA Z, Muraoka S, Kawazoe M, Hirose W, et al
   Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study.
   Arthritis Res Ther. 2024;26:87.
   PubMed         Abstract available
   
   

   
   Clin Exp Rheumatol

3. KIM JW, Shin K, Jung J, Suh CH, et al
   Uncovering risk factors for adverse events and infections in rheumatoid arthritis and rheumatoid arthritis with interstitial lung disease under treatment with biologics or targeted synthetic DMARDs: insights from the KOBIO Registry.
   Clin Exp Rheumatol. 2024 Apr 16. doi: 10.55563.
   PubMed         Abstract available
   
   
4. FORNARO M, Caporali R, Biggioggero M, Bugatti S, et al
   Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry.
   Clin Exp Rheumatol. 2024 Apr 17. doi: 10.55563.
   PubMed         Abstract available
   
   

   
   Clin Rheumatol

5. LI H, Jin Y, He J
   Respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease: a retrospective study.
   Clin Rheumatol. 2024;43:1777.
   PubMed        
   
   
6. AN Q, Ma R, Yuan D, Huang J, et al
   Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia.
   Clin Rheumatol. 2024;43:1491-1501.
   PubMed         Abstract available
   
   
7. CAI B, Guo Z, Yan Q, Li H, et al
   Clinical features and risk factors of primary Sjogren's syndrome complicated with severe pneumonia: a case-control study.
   Clin Rheumatol. 2024;43:1665-1674.
   PubMed         Abstract available
   
   
8. LU L, Dai T, Zhao Y, Qu H, et al
   The value of MRI-based radiomics for evaluating early parotid gland injury in primary Sjogren's syndrome.
   Clin Rheumatol. 2024;43:1675-1682.
   PubMed         Abstract available
   
   
9. XU N, Wang X, Dai T, Liu N, et al
   Non-invasive imaging for predicting labial salivary gland biopsy outcomes in patients with suspected primary Sjogren syndrome.
   Clin Rheumatol. 2024;43:1683-1692.
   PubMed         Abstract available
   
   
10. YETISIR A, Sariyildiz A, Turk I, Coskun Benlidayi I, et al
    Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors.
    Clin Rheumatol. 2024 Apr 15. doi: 10.1007/s10067-024-06963.
    PubMed         Abstract available
    
    
11. LITTLEJOHN G, Anbumurali N, O'Sullivan C, Smith T, et al
    Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.
    Clin Rheumatol. 2024 Apr 18. doi: 10.1007/s10067-024-06967.
    PubMed         Abstract available
    
    

    
    Eur J Immunol

12. XU Z, Moreno-Giro A, Zhao D, Kramer A, et al
    Fcgr2b and Fcgr3 are the major genetic factors for cartilage antibody-induced arthritis, overriding the effect of Hc encoding complement C5.
    Eur J Immunol. 2024;54:e2350659.
    PubMed         Abstract available
    
    

    
    J Rheumatol

13. BURMESTER GR, Van den Bosch F, Tesser J, Shmagel A, et al
    Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT).
    J Rheumatol. 2024 Apr 15:jrheum.2023-1062. doi: 10.3899/jrheum.2023-1062.
    PubMed         Abstract available
    
    

    
    PLoS One

14. LI R, Yuan X, Ou Y
    Global burden of rheumatoid arthritis among adolescents and young adults aged 10-24 years: A trend analysis study from 1990 to 2019.
    PLoS One. 2024;19:e0302140.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

15. THOMAS MA, Naik P, Wang H, Giles JT, et al
    The monocyte cell surface is a unique site of autoantigen generation in rheumatoid arthritis.
    Proc Natl Acad Sci U S A. 2024;121:e2304199121.
    PubMed         Abstract available
    
    

    
    Rheumatol Int

16. PUROHIT R, Bhaskar N, Jehu T, Camargo Macias K, et al
    Patient-reported outcomes of curcumin supplementation in rheumatoid arthritis and psoriatic arthritis: a cross-sectional survey.
    Rheumatol Int. 2024 Apr 16. doi: 10.1007/s00296-024-05577.
    PubMed         Abstract available
    
    

    
    Scand J Rheumatol

17. PROVAN SA, Ahlfors F, Bakland G, Hu Y, et al
    A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study.
    Scand J Rheumatol. 2024;53:173-179.
    PubMed         Abstract available
    
    
18. GERTEL S, Rokach M, Polachek A, Litinsky I, et al
    Anti-inflammatory effects of infliximab and methotrexate on peripheral blood and synovial fluid mononuclear cells: ex vivo study.
    Scand J Rheumatol. 2024;53:188-198.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.